NL
BIIB icon

NWAM LLC’s Biogen BIIB Stock Holding History

NWAM LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552K Buy
2,553
+1,412
+124% +$270K 0.03% 427
2026
Q1 		$209K Buy
+1,141
New +$210K 0.01% 587
2024
Q4 		– Sell
-1,152
Closed -$223K – 597
2024
Q3 		$223K Sell
1,152
-173
-13% -$36.2K 0.01% 567
2024
Q2 		$307K Buy
1,325
+1
+0.1% +$217 0.09% 110
2024
Q1 		$290K Buy
1,324
+78
+6% +$18.3K 0.02% 440
2023
Q4 		$322K Buy
1,246
+80
+7% +$19.6K 0.03% 424
2023
Q3 		$300K Sell
1,166
-92
-7% -$24.6K 0.03% 387
2023
Q2 		$358K Sell
1,258
-7
-0.6% -$2.08K 0.03% 381
2023
Q1 		$352K Buy
1,265
+5
+0.4% +$1.38K 0.04% 335
2022
Q4 		$349K Sell
1,260
-49
-4% -$13.8K 0.03% 386
2022
Q3 		$350K Buy
1,309
+118
+10% +$25.1K 0.03% 357
2022
Q2 		$253K Sell
1,191
-493
-29% -$101K 0.02% 436
2022
Q1 		$355K Sell
1,684
-6
-0.4% -$1.3K 0.03% 388
2021
Q4 		$405K Buy
+1,690
New +$435K 0.03% 364

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NWAM LLC's BIIB Position: Q2 2026 in Review

NWAM LLC increased its Biogen (BIIB) stake by 124% in Q2 2026, buying an estimated $270K and bringing the position to 2,553 shares worth $552K. The position accounts for 0.03% of the portfolio, ranked #427.

NWAM LLC first reported a position in BIIB in Q4 2021 and has held it in 14 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • NWAM LLC held 2,553 shares of Biogen worth $552K as of Q2 2026.
  • NWAM LLC bought 1,412 Biogen shares in Q2 2026, an estimated $270K.
  • Biogen made up 0.03% of NWAM LLC's portfolio in Q2 2026, its #427 holding.
  • NWAM LLC first reported a position in Biogen in Q4 2021 and has held it in 14 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.